5 Gene therapy products, namely, pharmaceutical preparation vectors for use in gene therapy, clinical medical reagents, therapeutic compositions containing vectors for gene therapy for use in the treatment of cancer, neurological, ocular, hearing, balance and auto-immune disorders; enzymes and enzyme preparations for gene therapy purposes, retroviral vector and retroviral vector manufacturing preparations, all for the field of gene therapy, for the treatment of prostate cancer